home / United States / Galectin Therapeutics

Galectin Therapeutics Market Cap

$75.94 M

-1.26 M

NASDAQ:GALT · January 22, 2025

Share price

$1.21

Enterprise Value

$0.24 B

Change (1-Year)

-27.9%

Global Rank

#7897

Country Rank

#3133

Regions

USA

Market cap

As of January 22, 2025, Galectin Therapeutics (GALT) has a market cap of $75.942 million USD. According to our data, Galectin Therapeutics is ranked No.7897 in global market value.

Sector Rank:

Biotech #592 Pharmaceuticals #537

GALT Market Capitalization Growth

30D Growth:

47.6%

1 Years Growth:

-27.9%

3 Years Growth:

-37.4%

5 Years Growth:

-56.9%

10 Years Growth:

-63.6%

15 Years Growth:

-33.3%

20 Years Growth:

-92.4%

Total Growth:

-89%

Galectin Therapeutics Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Galectin Therapeutics Market Cap CAGR Chart

Galectin Therapeutics Market Cap History 2002 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$75.94 M	-6.20%
Dec 31, 2024	$80.96 M	-22.29%
Dec 29, 2023	$0.10 B	46.90%
Dec 30, 2022	$70.92 M	-45.41%
Dec 31, 2021	$0.13 B	-7.59%
Dec 31, 2020	$0.14 B	-21.68%
Dec 31, 2019	$0.18 B	-16.62%
Dec 31, 2018	$0.22 B	2.69%
Dec 29, 2017	$0.21 B	240.82%
Dec 30, 2016	$61.51 M	-40.24%
Dec 31, 2015	$0.10 B	-52.74%
Dec 31, 2014	$0.22 B	-57.05%
Dec 31, 2013	$0.51 B	294.15%
Dec 31, 2012	$0.13 B	-64.41%
Dec 30, 2011	$0.36 B	6.67%
Dec 31, 2010	$0.34 B	221.43%
Dec 31, 2009	$0.11 B	211.11%
Dec 31, 2008	$33.89 M	-87.14%
Dec 31, 2007	$0.26 B	55.56%
Dec 29, 2006	$0.17 B	-85.25%
Dec 30, 2005	$1.15 B	22.00%
Dec 31, 2004	$0.94 B	-36.71%
Dec 31, 2003	$1.49 B	36.21%
Dec 31, 2002	$1.09 B	100%

Similar Companies to Galectin Therapeutics

Name	Market Cap	Market cap difference	Regions
Madrigal Pharmaceuticals MDGL	$7.08 B	-0.000 M	USA
Gilead Sciences GILD	$115.95 B	0.002 M	USA
Bristol-Myers Squibb BMY	$115.79 B	-0.003 M	USA
Novartis NVS	$196.27 B	-0.007 M	Switzerland
Merck MRK	$242.04 B	-0.000 M	USA
Pfizer PFE	$147.40 B	-0.003 M	USA
AstraZeneca AZN	$211.49 B	0.007 M	UK
Eli Lilly LLY	$678.07 B	0.022 M	USA
AbbVie ABBV	$299.00 B	-0.007 M	USA
Amgen AMGN	$146.98 B	0.004 M	USA
Biogen BIIB	$20.80 B	0.000 M	USA
Regeneron Pharmaceuticals REGN	$74.73 B	1.236 B	USA

About Galectin Therapeutics Inc.

Name

Galectin Therapeutics Inc.

Website

https://galectintherapeutics.com

Headquarters

Norcross,GA

symbol

GALT

CURRENCY

USD

country

United States

fullTimeEmployees

exchange

NCM

firstTradeDateEpochUtc

2002/09/04

GALT Market Cap Formula

Market Cap	=	GALT Stock Price	*	GALT Shares Outstanding
	=	$1.21	*	62.76 M
	=	$75.94 M

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe